Viewing Gene With Clinical Trials Data


Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/

Symbol: ERCC1
Name: ERCC excision repair 1 endonuclease non-catalytic subunit
Location: 19q13.32
Locus Group: protein-coding gene
Gene Type: Protein Coding
Locus Type: gene with protein product

Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all

Clinical Studies

NCT Number Status Brief Title View
NCT01444547 A Study on Predictive Value of ERCC1 in Esophageal Cancer Patients Treated With Paclitaxel and Cisplatin View
NCT00953511 Cologne Esophageal Response Prediction Study CERP-Study View
NCT01556191 Lung Cancer in Women Treated With Anti-oestrogens anD Inhibitors of EGFR View
NCT01240590 A Phase III Trial of Crolibulin EPC2407 Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer ATC View
NCT01989546 Pilot Trial of BMN 673 an Oral PARP Inhibitor in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations View
NCT01074398 Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182 View
NCT00174629 GILT Docetaxel - Non-Small Cell Lung Cancer View
NCT02838745 Study of Cytoreductive Surgery and Hyperthermic Intraoperative Chemotherapy With Pemetrexed and Cisplatin for MPM View
NCT04466189 Prospective Cohort Study of Pancreatic Cancer Patients Treated With Proton Beam Therapy View
NCT00582634 Adjuvant Cisplatin and Docetaxel in Non Small Cell Lung Cancer View
NCT00736814 First-Line Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery View
NCT00792701 S0720 Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung Cancer View
NCT02128906 Radiotherapy With Cisplatin vs Docetaxel-cetuximab in HNSCC ERCC1 Biomarker Enrichment and Interaction Design View
NCT01188109 GemcitabineCisplatin for Resected Pancreas Cancer Establishing the Role of ERCC1 in Treatment Decision View
NCT01280643 Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer View
NCT01781988 Personalized Therapy in Non-small Cell Lung Cancer View
NCT01784549 Customized Neoadjuvant Versus Standard Chemotherapy in NSCL Patients With Resectable Stage IIIA N2Disease View
NCT01524575 Gemcitabine and Oxaliplatin in the Management of Metastatic Pancreatic Cancers With Low Expression of ERCC1 View
NCT01648517 Genotype-Driven Treatment of Advanced Non-small Cell Lung Cancer Based on mRNA Expression of ERCC1 RRM1 as First-line Chemotherapy View
NCT01703390 Biomarker Directed Treatment in Metastatic Colorectal Cancer View
NCT01967875 A Phase 2 Trial of Optimizing Platinum-Based Chemotherapy Based on ERCC1 Expression as First-Line Treatment in Patients With Locally Advanced or Metastatic Gastric Cancer View
NCT03402048 The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial View
NCT00006155 SU5416 and Carboplatin to Treat Ovarian Cancer View
NCT05247671 Evaluation of the Effect of Genetic Polymorphisms in ERCC1 and OCT2 on the Occurrence and Severity of Cisplatin-induced Nephrotoxicity View
NCT05832593 Immunohistochemical Expression of Excision Repair Cross Complementation Group 1 ERCC1 in Laryngeal Squamous Cell Carcinoma and Its Correlation With Response to Radiotherapy View
NCT01071655 Selecting Treatment in Colorectal CancerCapecitabine or 5-fluorouracil Selection to be Combined With Oxaliplatin or Irinotecan as First-line Chemotherapy in Advanced Colorectal Cancer View
NCT01141686 Non Small Cell Lung Cancer Evaluation According to Pre-determined Drug-targeting Tumor Markers View
NCT00705549 Individualized Therapy Based of Tumoral mRNA Levels of ERCC1 RRM1 and BRCA1 in Advanced Non-Small-Cell Lung Cancer View
NCT01192750 Biomakers in Tissue Samples From Patients With Recurrent andor Metastatic Squamous Cell Cancer of the Head and Neck Previously Treated With Cisplatin With or Without Cetuximab View
NCT00499109 Phase III of RRM1 ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC View
NCT00634647 Satraplatin and Prednisone to Treat Prostate Cancer View
NCT00775385 TAilored Post-Surgical Therapy in Early Stage NSCLC View
NCT00797238 DNA Repair Genes and Outcomes in Patients With Stage III NSCLC View
NCT00801736 ERCC1 Targeted Trial View